Skip to content

Impact of socioeconomic status in GI cancer to Return in intended oncologic treatment (RIOT) and survival outcomes.

Impact of socioeconomic status in GI cancer to Return in intended oncologic treatment (RIOT) and survival outcomes.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20251229016
Enrollment
934
Registered
2025-12-29
Start date
2025-12-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RIOT in patients with gastrointestinal cancers, including stage II (high-risk) and stage III colorectal cancer, as well as stage II and stage III gastric cancer, who underwent curative surgery and planned adjuvant therapy Return to intended oncologic therapy (RIOT) Gastrointestinal cancers Socioeconomic status (SES)

Interventions

Patients who have a Composite Socioeconomic Status (SES) Score 2-4 points, adapted from the framework proposed by Galobardes et al. (2006) and modified to fit the Thai context.,Patients who have a Com
Other,Other
high socioeconomic status,low socioeconomic status

Sponsors

Suchavadee Toragsaskul, M.D.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with gastrointestinal cancers-including stage II (high-risk) and stage III colorectal cancer, as well as stage II and stage III gastric cancer-who underwent curative surgery and planned adjuvant treatment 2. Age 18 years and older 3. Histologically confirmed GI cancer (colorectal, gastric)

Exclusion criteria

Exclusion criteria: 1. Patients who underwent Palliative or R2 resection 2. Patients who had received preoperative chemotherapy for colon cancer 3. Patient who received subtotal or total colectomy or multivisceral organ resection which may impact the operation morbidity profile 4. Patients who loss follow-up within 3 months post-surgery or missing SES data

Design outcomes

Primary

MeasureTime frame
Return to intended oncologic therapy 8 weeks after surgery ability to received adjuvant treatment

Secondary

MeasureTime frame
Disease free survival from the date of surgery until the date of recurrence clinical follow-up, imaging, pathology, and medical records,Overall survival from the date of surgery until the date of death medical records, death certificates, or national death registry

Countries

Thailand

Contacts

Public ContactSuchavadee Toragsaskul

Faculty of Medicine Ramathibodi Hospital, Mahidol University

prawtoragsaskul@gmail.com022011315

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026